BPC-157
Body Protection Compound-157 · pentadecapeptide
Tendon, ligament and gastrointestinal lining repair; angiogenesis in injured tissue.
Research library
Every peptide we research. Not every peptide you will receive.
This is the complete set under review at MyPetGevity, listed together and on purpose. Which of them appear in a given pathway — in what order, over which months, and alongside what — is the part we have spent years working out, and the part we keep.
Why the list is undivided
Sorting these compounds into three neat buckets would misrepresent the research and give away the sequencing at the same time. Most of them touch more than one system.
What “under review” means
We read the literature, track new publications, and summarise what is credible and what is not. Appearing here means we are following it — not that we endorse it, and not that it is in any pathway.
Regulatory status
All compounds listed are investigational. None are FDA-approved for use in companion animals. Nothing on this page is a recommendation to administer anything to your pet.
Under review
Twenty compounds
Listed alphabetically within family. Research focus describes what the literature examines, not a claimed effect in your pet.
TB-500
Synthetic thymosin beta-4 fragment
Repair-cell migration, actin regulation and tissue remodelling after injury.
GHK-Cu
Copper tripeptide-1
Collagen and elastin synthesis; skin, coat and wound-bed research.
KPV
Lysine–proline–valine · α-MSH C-terminal fragment
Inflammatory signalling and mucosal inflammation models.
Thymosin α-1
Thymalfasin · 28-amino-acid thymic peptide
Immune modulation and T-cell function in aging animals.
Thymalin
Thymus peptide complex
Thymic involution and immune aging; long-running geroscience literature.
Epitalon
Epithalamin tetrapeptide · Ala-Glu-Asp-Gly
Telomerase expression, pineal function and circadian regulation.
FOXO4-DRI
FOXO4 D-retro-inverso peptide
Senescent-cell clearance; senolytic research in aged rodent models.
Humanin
Mitochondrial-derived peptide, 24 aa
Neuronal survival signalling and metabolic protection.
MOTS-c
Mitochondrial ORF of the 12S rRNA type-c
Metabolic homeostasis, insulin sensitivity and exercise-mimetic signalling.
SS-31
Elamipretide · cardiolipin-binding tetrapeptide
Inner mitochondrial membrane function and age-related muscle decline.
Semax
ACTH(4–10) heptapeptide analogue
BDNF expression, neuroprotection and cognition in animal models.
Selank
Tuftsin heptapeptide analogue
Anxiolytic and neuromodulatory activity without sedation in models.
Dihexa
Angiotensin IV analogue · N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide
Synaptogenesis, HGF/c-Met signalling and memory research.
Cerebrolysin
Porcine-derived neuropeptide preparation
Neurotrophic support and neurorecovery literature.
Ipamorelin
Pentapeptide growth-hormone secretagogue
Selective GH pulsatility with minimal cortisol or prolactin effect in models.
CJC-1295
GHRH(1–29) analogue
Growth-hormone axis signalling, lean mass and recovery research.
AOD-9604
hGH fragment 176–191
Adipose metabolism and cartilage-regeneration models.
LL-37
Human cathelicidin antimicrobial peptide
Antimicrobial activity, barrier defence and wound-healing research.
Larazotide
Octapeptide zonulin antagonist
Intestinal tight-junction integrity and barrier permeability.
What we do not publish. The composition of each six-month pathway — which compounds
appear, in what sequence, across which months, and in what combination — is proprietary to
MyPetGevity. Members receive their pathway’s modules month by month. We do not publish the
full sequence, and we do not publish dosing.
How we read a paper
Species, sample size, and who paid for it.
A great deal of peptide research is in rodents, in vitro, or in humans — and a great deal of what circulates online quietly drops that detail. Every summary in the member library states the model, the sample size, the funding source and what the study cannot tell you.
Where the evidence in companion animals is thin, we say so. That is more useful to you than a confident sentence we cannot support.
Every summary states
- Species and model — rodent, canine, feline, in vitro or human
- Sample size and study design
- Funding source and declared conflicts
- What the study does not establish
- A link to the source paper, always
The library is open to free members too.
Selected summaries and the weekly research email cost nothing. Full library access comes with a six-month pathway.